Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Atlantic Equities Upgrades Abbott Laboratories to Overweight, Announces $144 Price Target

Atlantic Equities analyst James Mainwaring upgrades Abbott Laboratories (NYSE:ABT) from Neutral to Overweight and announces $144 price target.
byBenzinga Newsdesk
October 27, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Atlantic Equities analyst James Mainwaring upgrades Abbott Laboratories (NYSE:ABT) from Neutral to Overweight and announces $144 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Zoom Had Disappointing Quarter, Faces Transition Year: Here’s Why Some Analysts Are Cutting Price Targets

By Chris Katje
Today, 11:59 AM
Video communications company Zoom Video Communications Inc (NASDAQ: ZM) reported earnings per share (EPS) that beat Street estimates and revenue which missed Street estimates on Monday. Analysts sized up the latest quarterly report and the company’s guidance.

ZM